Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One Inks Mayo Clinic MDx Alliance

NEW YORK (GenomeWeb) – N-of-One said today that it has signed an agreement to provide clinical interpretation support for the Mayo Clinic's molecular diagnostics testing.

N-of-One said that it will assist Mayo Medical Laboratories, a reference lab within Mayo Clinic's Department of Laboratory Medicine and Pathology, with biological and clinical knowledge and in identifying therapeutic options and potential clinical trials for patients who have their tumors sequenced. The Lexington, Mass.-based bioinformatics firm also will provide support services for Mayo's Center for Individualized Medicine.

Further terms of the alliance were not disclosed.

"With the rapidly increasing volume of clinical and scientific data, and hundreds of drugs currently in clinical trials, the task of interpreting molecular test results has become increasingly challenging," N-of-One CEO Chris Cournoyer said in a statement. "We are committed to providing scalable, cost-effective genomic clinical decision support that delivers valuable analysis and interpretation of the relevant clinical data to support oncologists in making molecularly informed treatment decisions for their patients."

N-of-One recently signed similar deals with the Dartmouth-Hitchcock Medical Center and with Cedars-Sinai Medical Center's Cancer Institute.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.